Lv7
4558 积分 2021-08-05 加入
CAR-X cell engineering
7天前
已完结
Autologous CD19 CAR T-cell therapy for pediatric and adult systemic lupus erythematosus: a phase 1/2 trial
14天前
已完结
Upadacitinib Versus Tofacitinib in Anti‐ MDA5 ‐Positive Dermatomyositis With Interstitial Lung Disease: A Multi‐Centre Cohort Study Emulating a Target Trial
25天前
已完结
Validation of EULAR primary Sjögren’s syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)
1个月前
已完结
EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjögren's syndrome
1个月前
已完结
BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy
1个月前
已完结
Bispecific T cell engagers for treatment-refractory autoimmune connective tissue diseases
2个月前
已完结
Microenvironmental niches dictate divergent fibroblast fates in reversible versus progressive lung fibrosis
2个月前
已完结
The U.S. Food and Drug Administration’s Perspective on Chimeric Antigen Receptor T-Cell Therapies for Autoimmune and Rheumatic Conditions
3个月前
已完结
China’s innovation in translational medicine: rethinking early-stage clinical development
3个月前
已完结
皖公网安备34019202002308
